All Stories

  1. Bone Tumor Metastasis Therapeutics, New Ideas and Perspectives
  2. COVID 19 Study, Drug Selection and Development
  3. Anticancer Drug Combinations: Different Strategies Used in the Clinic
  4. Cancer Bioinformatics, New Chapter of Personalized Medicine
  5. Pulmonary nodules, knowledge renovation and comprehensive studies
  6. Personalized Oncology: Scientific and Technical Approaches
  7. Advances in Cancer Therapeutics and Genomics for Improved Patient Outcomes
  8. Magnetic water and clinical cancer chemotherapy
  9. Nursery Services in Future
  10. Human suicide, clinical treatment overview
  11. Sexually transmitted disease diagnosis and treatments, risk factors from beyond
  12. Human suicide, risk factors and new perspective
  13. Suicide study, new approaches
  14. Human suicide, molecular framework
  15. COVID-19 knowledge and therapeutics, past, present and future
  16. Artificial intelligence for advancing nursery service
  17. Treatment improvements by pediatric Theranostics
  18. COVID-19 conception advances, epidemics, pathology and therapeutics
  19. Withdrawn: Professor Bin Xu, A Legendary Pharmacologist in People’s Republic of China
  20. Sialic Acids and Cancer: Pathophysiological Association between Metastatic Progress and Treatment
  21. Anticancer Drug Development, Pharmaceutical Progress
  22. Human Suicide, Biomedical Knowledge Advances
  23. Type 2 Diabetes Treatments in Countries of Different Economic Status
  24. Human suicide, biomedical knowledge and therapeutic advances
  25. Human Suicide, an Overview of Management Strategies
  26. COVID-19 Research, Public Health and Biomedical Basis
  27. Human Suicide, Management Landscape
  28. Anticancer Drug Development: Evaluative Architecture
  29. COVID-19 Study: A New Principle Discovery
  30. COVID-19 Study, Diagnostic and Therapeutic Transition
  31. Antimetastatic Drug, Pharmacologic Challenge and Opportunity
  32. Nursery services advances, global campaign
  33. Different approaches to bone transplantation surgery
  34. Bone Metastasis Diagnosis, Blood Biomarker Detections
  35. Anti-metastatic drug development, overview and perspectives
  36. Educational Perspectives for Nursery
  37. Is Tau Molecule Regarded as a Risk Factor for Human Suicide?
  38. Drug Sensitivity Testing for Cancer Therapy, Technique Analysis and Trends
  39. Suicide Curative Treatment Study and Drug Development
  40. Pulmonary nodules, is there any pathogenesis evidence?
  41. HIV/AIDS Curability Study, Different Approaches and Drug Combination
  42. Pulmonary nodules, surgery or other medication
  43. Bone Metastasis and Circulation Biomarkers Profiling Towards Personalized Cancer Medicine
  44. Pulmonary Nodules, Surgery or Other Medication
  45. Anti-Metastatic Drug Developments, Utility of More Animal Models
  46. Several approaches for anticancer drug development progress
  47. Drug Sensitivity Testing for Cancer Therapy, Key Areas
  48. COVID-19 infection for metabolic abnormal human beings
  49. Fundamental knowledge for nurses 
  50. Nursery promotion, education and system updating
  51. Cancer Bone Metastasis, Diagnostic Insights and Drug Selection
  52. Covid-19 Study, Pathology and Therapeutics
  53. Acupuncture for Bone Disease Treatments, Modern Approaches
  54. Cancer Bone Metastasis, Experimental Study
  55. Neuropsychiatric Approaches for Human Suicide Prediction and Management
  56. Osteoporosis Targeting, Possible Breakthroughs
  57. Neuropsychiatric insights for human suicide
  58. Bone Cancer and Metastasis Trials, Drug Treatment
  59. Neurobiology for human suicide
  60. Bone Disease Treatment Study, Major Pathways
  61. Pathology Study for Human Suicide
  62. Nursery activity and quality, chemistry between doctors and nurses
  63. Nursery education, narrow-range or wide-range
  64. Anticancer drug development, challenge and dilemma
  65. Life Origin on Earth, Knowledge Development
  66. HIV/AIDS treatment, therapeutic strategy break throughs
  67. Nursery education for diabetes
  68. Suicide Risks and Prevention, Neuropathogenic Study
  69. Medical Treatments for Chronic or Aggressive Diseases, Palliative Therapy and Nursery
  70. General information for nursery
  71. Historical analysis of suicide
  72. Drug sensitivity testing, a unique drug selection strategy
  73. Natural drug cancer treatments, strategies from herbal medicine to chemical or biological drugs
  74. Medical treatments for incurable diseases, palliative therapy
  75. Life Origin on Earth, Biochemical Approaches
  76. Nursery training, from technique details in schools into medical knowledge education in nursery career
  77. Herbal medicine in new era
  78. Nursery service, quality promotion
  79. Anti-Metastatic Drug Developments, Biomedical Mechanisms and Therapeutic Categorization
  80. RETRACTED: Aberrant Sialylation in Cancer Pathology and Metastasis, a Putative Drug Target Candidate
  81. Patient’s care and nursery in different diseases
  82. Ebola Therapeutic Study and Future Directions
  83. New HIV/AIDS Therapeutics
  84. Nursery Service in Modern Days
  85. Nursery Education, Capability and Service Promotion
  86. Nursery Science and Conventions
  87. Cancer Bioinformatics in Cancer Therapy
  88. Individualized Cancer Therapy
  89. Human Suicide Risk and Treatment Study
  90. Type 2 Diabetes Treatment and Drug Development Study
  91. Hypotheses for Life Origin on Earth, Comparison and Validation
  92. Type 2 Diabetes Study, Introduction and Perspective
  93. Type 2 Diabetes Mellitus Study, A Process of Enigma unraveling
  94. Anthocyanins and its biological & therapeutic characters
  95. Diabetes Prevention and Treatments, a Specific Topic for Modern Medicines
  96. A Critical Appraisal of Different Food Safety and Quality Management Tools to Accomplish Food Safety
  97. Pathology and treatments of obesity
  98. Obesity, Risks and Managements
  99. Keep up the pace of drug development evolution and expenditure
  100. An Overview of Obesity
  101. General Topics in the Field of Personalized Cancer Therapy
  102. Human Suicide Risk Study and Treatment: A Mathematical Approach
  103. Anti-Metastatic Drug Developments: Work Out towards New Direction
  104. Diabetes Mellitus and Male Aging: Pharmacotherapeutics and Clinical Implications
  105. Drug Combination in Clinical Cancer Treatments
  106. General outlook for individualized cancer therapy
  107. Ebola origin and treatment
  108. Different Disciplines in the Field of Suicide Study
  109. Cancer Bioinformatics for Updating Anticancer Drug Developments and Personalized Therapeutics
  110. HAART in HIV/AIDS Treatments
  111. Anticancer Drug Development, System Updating and Global Participations
  112. Life Origin on Earth, What is the Right Answer?
  113. Life Origin on Earth, What is the Right Answer?
  114. Anticancer Drug Development, Getting out from Bottleneck
  115. Anticancer Drug Development, Getting out from Bottleneck
  116. Human suicide study, major disciplines and treatment outcomes
  117. Anticancer drug development
  118. HIV in Human Genomes and Therapeutics
  119. HIV Biotherapy and Natural Chemotherapeutic Agents
  120. Anticancer Drug Combinations, How Far We can Go Through?
  121. Antimetastatic therapy at aberrant sialylation in cancer cells, a potential hotspot
  122. Life Origin on Earth, Insights among Different Arguments
  123. Genetics in Suicide Treatments, Modern Diagnosis Establishments
  124. Diabetes Preventions and Treatments, a Specific Topic for Modern Medicines
  125. Anticancer Drug Development, Breakthroughs are Waiting
  126. Cancer metastasis treatment, a key drawbacks
  127. The suicide treatment, a new model
  128. HIV Vaccine for Prevention and Cure, A Mission Possible
  129. Zika Therapy
  130. HIV vaccine
  131. Discover Natural Chemical Drugs in Modern Medicines
  132. Mathematics in biomedical science
  133. The origin of HIV
  134. Human suicide study
  135. Mathematics or Physics-Majored Students on the Biomedical Fields, Insiders or Outsiders?
  136. Pharmacogenetics of Cancer Therapy
  137. Anticancer Drug Sensitivity Testing
  138. New Perspectives of HIV/AIDS Therapy Study
  139. Antidepressant treatment study
  140. Clinical neoplasm metastasis treatments according to patient's personal conditions.
  141. Assistant cancer treatments in the clinic
  142. Drug sensitivity testing in clinical cancer treatments
  143. Anticancer drug combination in the clinic
  144. Anticancer drug pharmacogenomics in cancer chemotherapy
  145. Cost-effectiveness for personalized cancer therapy
  146. Conclusion
  147. Introduction
  148. Discussion
  149. Cancer biomarker/bioinformatics detection in clinical cancer treatments
  150. Anti-diabetic treatments
  151. Anticancer Drug Combinational Study
  152. The Origins of HIV
  153. Plasma Fibrinogen Concentrations in Patients with Solid Tumors and Therapeutic Improvements by Combining Anticoagulants or Fibrinolytical Agents
  154. Anticancer Drug Combinations, A Big Momentum is Needed
  155. Anticancer Drug Development, a Matter of Money or a Matter of Idea?
  156. Future Perspectives for Controlling Ebola Epidemics
  157. Ebola Origin and Therapies
  158. Cancer Bioinformatics, its Impacts on Cancer Therapy
  159. Copyright
  160. List of figures and tables
  161. Anti-diabetic treatments, patho-therapeutic relation
  162. Origin of Ebola, hypothesis
  163. Personalized Cancer Therapy: A Perspective
  164. Rethink Of Diabetes Treatment and Drug Development
  165. Pharmacogenomics in human suicide prediction and treatments
  166. Cancer metastasis treatment study and drug developments
  167. Challenge for HIV/AIDS therapy
  168. Cost-effectiveness Considerations of Individualized Cancer Chemotherapy
  169. Drug Combinations in Cancer Treatments
  170. New Insights into Individualized Antimetastatic Therapy
  171. Anticancer drugs on serum sialic acid level in mice bearing LLC
  172. Drug Combinations in Cancer Treatments
  173. Genetics in Neural Toxicity of Drugs
  174. Avian flu, pathogenesis and therapeutic study
  175. First Genetic Information Replication in Life Origin on Earth
  176. Origins of Life, A New Cooperative Model
  177. Cancer Metastases and Clinical Therapies
  178. Origins of Life, RNA world or alternative RNA world
  179. Development of Antimetastatic Drugs by Targeting Tumor Sialic Acids
  180. Individualized Cancer Chemotherapy by Detecting Cancer Biomarkers
  181. Antimetastatic Therapies according to Metastatic Cascade
  182. Genetics in antidepressant-induced suicide
  183. Pathology of Drug-induced mania & suicide
  184. Influenza treatment
  185. High Active Anti-retroviral Therapy for HIV/AIDS, Progresses and Drawback
  186. Individualized cancer chemotherapy
  187. High Active Antiretroviral Therapy for HIV/AIDS-Early Intervention or Later Intervention?
  188. The Hypotheses for the Pathogeny of Drug-Induced Mania and Suicide
  189. The Relationship between Tumor Sialic Acids and Neoplasm Metastasis and as a Drug Target
  190. Genomic study of antidepressant-induced suicide
  191. Aberrant sialylation in tumor cells
  192. Anti-mobility of Bisdioxopiperanes against human mammary tumors
  193. Antimetastatic activity and mechanisms of action of Bisdioxopiperazine compounds
  194. Neural toxicity of drugs
  195. Anticancer activity and mechanisms of Bisdioxopiperazines
  196. Different Spontaneous Pulmonary Metastasis Inhibitions against Lewis Lung Carcinoma in Mice by Bisdioxopiperazine Compounds of Different Treatment Schedules
  197. 14C-probimane in the mice bearing LLC
  198. Unsatisfactory design of human AIDS genome research
  199. Antidepressant in Cancer Treatment
  200. AIDS and human genome studies, from a hypothesis to systematic approaches
  201. Antidepressants in Human suicide
  202. Mathematical model in therapeutic risk prediction
  203. Fibrinogen in neoplasm metastasis
  204. Sequencing the whole genome of infected human cells obtained from diseased patients – a proposed strategy for understanding and overcoming AIDS or other deadest virus-infected diseases
  205. Relationship Between Blood Fibrinogen Concentration and Pathological Features of Cancer Patients: A 139-case Clinical Study
  206. Medicinal Chemistry of Probimane and MST-16: Comparison of Anticancer Effects Between Bisdioxopiperazines
  207. Individualized cancer chemotheray
  208. Anti-proliferative and chromosome segregation by probimane and MST-16
  209. Effect of Anti-Cancer Drugs on the Binding of 125I-Fibrinogen to Two Leukaemia Cell Lines In Vitro
  210. Antitumor effects of two bisdioxopiperazines against two experimental lung cancer models in vivo
  211. Inhibition of probimane on lipid peroxidation of rabbit and human erythrocytes
  212. Aberration of sialylation in neoplasm metastasis and possible therapeutics
  213. Effects of Cancer Chemotherapy on the Blood Fibrinogen Concentrations of Cancer Patients
  214. Effect of magnetized water on the mice given high doses of antineoplastic drugs
  215. Inhibition of probimane on lipoperoxidation of human red cells in vitro
  216. Enzyme dynamic study on calmodulin Ca++-Mg++-ATPase system of red blood cells inhibited by α-anordrin and probimane
  217. Journal of Clinical and Medical Reviews